特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
938946

エピネフリン自動注射器

Epinephrine Auto-injector

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 176 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

エピネフリン自動注射器
出版日: 2020年07月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

COVID-19による危機と迫り来る経済不況の中で、世界のエピネフリン自動注射器市場は、予測期間中5.6%で成長する見込みです。注射液0.15gmセグメントは6%以上の成長が見込まれ、予測期間中末までに19億米ドルに達すると予測されています。新しいシナリオでは米国のCAGRが6.6%に見直されています。日本の注射液0.15gmセグメントは、予測期間末までに1億3120万米ドルに達する見込みです。

当レポートでは、世界のエピネフリン自動注射器市場について調査し、市場の概要、COVID-19が及ぼす影響、地域・国別による分析と予測、および主要企業のプロファイルなど、体系的な情報を提供しています。

第1部 イントロダクション・調査手法・調査範囲

第2部 エグゼクティブサマリー

第1章 市場概要

  • 世界の競合企業の市場シェア
  • 競合企業の市場シェアシナリオ
  • Covid-19の影響と迫り来る世界の景気後退

第2章 主要企業

第3章 市場動向・促進要因

第4章 世界市場の見通し

第3部 市場分析

  • 地域別市場分析
  • 米国
    • 市場データ
    • 米国のエピネフリン自動注射器の市場シェア、企業別
    • 市場分析
  • カナダ
  • 日本
  • 中国
  • 欧州
    • 市場データ
    • 競合企業の市場シェアシナリオ
    • 市場分析
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • その他

第4部 競合

  • 企業プロファイル
目次
Product Code: MCP11840

Global Epinephrine Auto-injector Market to Reach $2.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Epinephrine Auto-injector estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027. 0.15gm Dosage, one of the segments analyzed in the report, is projected to record a 6% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the 0.30gm Dosage segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $535 Million, While China is Forecast to Grow at 5.2% CAGR

The Epinephrine Auto-injector market in the U.S. is estimated at US$535 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$467.1 Million by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

0.5gm Dosage Segment to Record 3.5% CAGR

In the global 0.5gm Dosage segment, USA, Canada, Japan, China and Europe will drive the 3.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$108.9 Million in the year 2020 will reach a projected size of US$138.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$304.9 Million by the year 2027.We bring years of research experience to this 7th edition of our report. The 176-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Adamis Pharmaceuticals Corporation
  • ALK-Abello AS
  • Antares Pharma, Inc.
  • Bausch + Lomb UK Ltd- Emerade
  • Hospira, Inc.
  • Impax Laboratories, Inc.
  • Lincoln Medical
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

  • I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Epinephrine Autoinjector Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Epinephrine Auto-injector Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Epinephrine Auto-injector Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
  • TABLE 3: Epinephrine Auto-injector Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: 0.15gm Dosage (Dosage) World Market by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 5: 0.15gm Dosage (Dosage) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 6: 0.15gm Dosage (Dosage) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: 0.30gm Dosage (Dosage) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: 0.30gm Dosage (Dosage) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
  • TABLE 9: 0.30gm Dosage (Dosage) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: 0.5gm Dosage (Dosage) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 11: 0.5gm Dosage (Dosage) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
  • TABLE 12: 0.5gm Dosage (Dosage) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Hospitals & Clinics (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027
  • TABLE 14: Hospitals & Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
  • TABLE 15: Hospitals & Clinics (End-Use) Share Breakdown Review by Region/Country:
  • 2012 VS 2020 VS 2027
    • TABLE 16: Individuals (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 17: Individuals (End-Use) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019
    • TABLE 18: Individuals (End-Use) Distribution of Global Sales by Region/Country:
  • 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Epinephrine Autoinjector Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 19: United States Epinephrine Auto-injector Market Estimates and Projections in US$ Thousand by Dosage: 2020 to 2027
    • TABLE 20: Epinephrine Auto-injector Market in the United States by Dosage: A Historic Review in US$ Thousand for 2012-2019
    • TABLE 21: United States Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 22: United States Epinephrine Auto-injector Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 23: Epinephrine Auto-injector Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019
    • TABLE 24: Epinephrine Auto-injector Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
  • CANADA
    • TABLE 25: Canadian Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020 to 2027
    • TABLE 26: Canadian Epinephrine Auto-injector Historic Market Review by Dosage in US$ Thousand: 2012-2019
    • TABLE 27: Epinephrine Auto-injector Market in Canada: Percentage Share Breakdown of Sales by Dosage for 2012, 2020, and 2027
    • TABLE 28: Canadian Epinephrine Auto-injector Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 29: Epinephrine Auto-injector Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
    • TABLE 30: Canadian Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • JAPAN
    • TABLE 31: Japanese Market for Epinephrine Auto-injector: Annual Sales Estimates and Projections in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 32: Epinephrine Auto-injector Market in Japan: Historic Sales Analysis in US$ Thousand by Dosage for the Period 2012-2019
    • TABLE 33: Japanese Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 34: Japanese Demand Estimates and Forecasts for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 35: Japanese Epinephrine Auto-injector Market in US$ Thousand by End-Use: 2012-2019
    • TABLE 36: Epinephrine Auto-injector Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
  • CHINA
    • TABLE 37: Chinese Epinephrine Auto-injector Market Growth Prospects in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 38: Epinephrine Auto-injector Historic Market Analysis in China in US$ Thousand by Dosage: 2012-2019
    • TABLE 39: Chinese Epinephrine Auto-injector Market by Dosage: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 40: Chinese Demand for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 41: Epinephrine Auto-injector Market Review in China in US$ Thousand by End-Use: 2012-2019
    • TABLE 42: Chinese Epinephrine Auto-injector Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Epinephrine Autoinjector Market: Competitor Market Share Scenario (in %)
    • for 2019 & 2025
    • Market Analytics
    • TABLE 43: European Epinephrine Auto-injector Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
    • TABLE 44: Epinephrine Auto-injector Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
    • TABLE 45: European Epinephrine Auto-injector Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
    • TABLE 46: European Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020-2027
    • TABLE 47: Epinephrine Auto-injector Market in Europe in US$ Thousand by Dosage: A Historic Review for the Period 2012-2019
    • TABLE 48: European Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 49: European Epinephrine Auto-injector Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 50: Epinephrine Auto-injector Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
    • TABLE 51: European Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • FRANCE
    • TABLE 52: Epinephrine Auto-injector Market in France by Dosage: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 53: French Epinephrine Auto-injector Historic Market Scenario in US$ Thousand by Dosage: 2012-2019
    • TABLE 54: French Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 55: Epinephrine Auto-injector Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
    • TABLE 56: French Epinephrine Auto-injector Historic Market Review in US$ Thousand by End-Use: 2012-2019
    • TABLE 57: French Epinephrine Auto-injector Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • GERMANY
    • TABLE 58: Epinephrine Auto-injector Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 59: German Epinephrine Auto-injector Historic Market Analysis in US$ Thousand by Dosage: 2012-2019
    • TABLE 60: German Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 61: Epinephrine Auto-injector Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
    • TABLE 62: German Epinephrine Auto-injector Market in Retrospect in US$ Thousand by End-Use: 2012-2019
    • TABLE 63: Epinephrine Auto-injector Market Share Distribution in Germany by End-Use:
  • 2012 VS 2020 VS 2027
  • ITALY
    • TABLE 64: Italian Epinephrine Auto-injector Market Growth Prospects in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 65: Epinephrine Auto-injector Historic Market Analysis in Italy in US$ Thousand by Dosage: 2012-2019
    • TABLE 66: Italian Epinephrine Auto-injector Market by Dosage: Percentage Breakdown of Sales for 2012, 2020, and 2027
    • TABLE 67: Italian Demand for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 68: Epinephrine Auto-injector Market Review in Italy in US$ Thousand by End-Use: 2012-2019
    • TABLE 69: Italian Epinephrine Auto-injector Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 70: United Kingdom Market for Epinephrine Auto-injector: Annual Sales Estimates and Projections in US$ Thousand by Dosage for the Period 2020-2027
    • TABLE 71: Epinephrine Auto-injector Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Dosage for the Period 2012-2019
    • TABLE 72: United Kingdom Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 73: United Kingdom Demand Estimates and Forecasts for Epinephrine Auto-injector in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 74: United Kingdom Epinephrine Auto-injector Market in US$ Thousand by End-Use: 2012-2019
    • TABLE 75: Epinephrine Auto-injector Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020-2027
    • TABLE 77: Epinephrine Auto-injector Market in Rest of Europe in US$ Thousand by Dosage: A Historic Review for the Period 2012-2019
    • TABLE 78: Rest of Europe Epinephrine Auto-injector Market Share Breakdown by Dosage: 2012 VS 2020 VS 2027
    • TABLE 79: Rest of Europe Epinephrine Auto-injector Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 80: Epinephrine Auto-injector Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
    • TABLE 81: Rest of Europe Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 82: Epinephrine Auto-injector Market in Asia-Pacific by Dosage: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 83: Asia-Pacific Epinephrine Auto-injector Historic Market Scenario in US$ Thousand by Dosage: 2012-2019
    • TABLE 84: Asia-Pacific Epinephrine Auto-injector Market Share Analysis by Dosage: 2012 VS 2020 VS 2027
    • TABLE 85: Epinephrine Auto-injector Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
    • TABLE 86: Asia-Pacific Epinephrine Auto-injector Historic Market Review in US$ Thousand by End-Use: 2012-2019
    • TABLE 87: Asia-Pacific Epinephrine Auto-injector Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
  • REST OF WORLD
    • TABLE 88: Rest of World Epinephrine Auto-injector Market Estimates and Forecasts in US$ Thousand by Dosage: 2020 to 2027
    • TABLE 89: Rest of World Epinephrine Auto-injector Historic Market Review by Dosage in US$ Thousand: 2012-2019
    • TABLE 90: Epinephrine Auto-injector Market in Rest of World: Percentage Share Breakdown of Sales by Dosage for 2012, 2020, and 2027
    • TABLE 91: Rest of World Epinephrine Auto-injector Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 92: Epinephrine Auto-injector Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
    • TABLE 93: Rest of World Epinephrine Auto-injector Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 44
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.